Lead sponsor
AC Immune SA
2 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
2
Trials led
1
Ongoing
361
Total enrollment
35
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1/2
2
Trials by status
Recruiting
1
Completed
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)MCI due to AD / prodromal ADPh 1/2Recruiting304
A Study to Evaluate the Safety, Tolerability and Immunogenicity of Tau Targeted Vaccines in Participants With Early Alzheimer's DiseaseAmyloid biomarker required (CSF)Ph 1/2Completed57